OHDSI Digest – June 12th, 2017

Patient-level prediction (Western hemisphere) WG meeting – Wednesday at 12pm ET

Population-Level Estimation (Eastern hemisphere) WG Meeting – Wednesday at 3pm Hong Kong time

NLP workgroup meeting – Wednesday at 2pm ET
Dial +1 (571) 317-3122 (United States)
Enter conference ID: 707-196-421
Screen Sharing: https://global.gotomeeting.com/join/707196421

Architecture WG meeting – Thursday at 1pm ET
Webex: https://jjconferencing.webex.com/mw3000/mywebex/default.do?service=1&main_url=%2Fmc3000%2Fe.do%3Fsiteurl%3Djjconferencing%26AT%3DMI%26EventID%3D283835502%26MTID%3Dmb7e839a762fbdaab0608f27500679223%26Host%3DQUhTSwAAAASTOYBxx2KWYTIL7ZSgHgHJoIHctjgxp8k5mgqAEPo2a1ESa12-8hjAVWbZznuDt96ugkT31G8sY5iSWLRwSwhI0%26FrameSet%3D2&siteurl=jjconferencing&nomenu=true

No OHDSI call this week – Tomorrow’s OHDSI call (12-1pm ET) has been cancelled. Our next call will be June 20th.

2017 OHDSI Symposium – The date and location for the 2017 OHDSI Symposium has been confirmed! This year’s symposium will take place on Wednesday, October 18th at the Bethesda North Marriott. Full-day tutorial sessions will take place on October 19-20th. Registration for the symposium here: https://www.ohdsi.org/symposium-registration/

Call for Sponsorship – To fund the 2017 symposium we need to raise $200K to cover operating costs of venue rental, lunch, audio/visuals and recordings fees. We’re reaching out to the entire community for sponsors who want to support this important event and allow us to build upon the success of past symposia. More details: http://forums.ohdsi.org/t/ohdsi-symposium-2017-call-for-sponsorship/2730?u=maurabeaton

Training opportunity – The Center for Pharmacoepidemiology Research and Training is offering a free seminar series on drug-drug interactions: http://mailchi.mp/mail/the-health-effects-of-drug-drug-interactions-a-webinar-series?e=3ea48f19e7

Wise men speak because they have something to say; Fools because they have to say something.
– Plato

Building a semantic web-based metadata repository for facilitating detailed clinical modeling in cancer genome studies

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.